{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2017-N-6189\" sorted by posted_date descending", "rows": [["FDA-2017-N-6189-7939", "FDA", "FDA-2017-N-6189", "Ref. 85_Donny_2015_Randomized trial of reduced-nicotine standard for cigarettes", "Supporting & Related Material", "Background Material", "2018-08-21T04:00:00Z", 2018, 8, null, null, "2018-08-21T18:52:20Z", null, 0, 0, "0900006483640913"], ["FDA-2017-N-6189-0650", "FDA", "FDA-2017-N-6189", "Tobacco Product Standard for Nicotine Level of Combusted Cigarettes;\nExtension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2018-06-08T04:00:00Z", 2018, 6, "2018-06-08T04:00:00Z", null, "2018-07-16T08:46:05Z", "2018-12368", 0, 0, "09000064833985aa"], ["FDA-2017-N-6189-0534", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from U.S. Tobacco Cooperative Inc.", "Other", "Request for Extension", "2018-05-24T04:00:00Z", 2018, 5, "2018-05-24T04:00:00Z", null, "2018-05-24T13:25:40Z", null, 0, 0, "09000064832c481d"], ["FDA-2017-N-6189-0531", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from The Heritage Foundation", "Other", "Request for Extension", "2018-05-23T04:00:00Z", 2018, 5, "2018-05-23T04:00:00Z", null, "2018-05-23T14:11:04Z", null, 0, 0, "09000064832c0e59"], ["FDA-2017-N-6189-0527", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from The Heartland Institute", "Other", "Electronic Regulation from Form", "2018-05-22T04:00:00Z", 2018, 5, "2018-05-22T04:00:00Z", null, "2018-05-22T20:00:15Z", null, 0, 0, "09000064832b2752"], ["FDA-2017-N-6189-0484", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period form Kentucky Farm Bureau Federation", "Other", "Request for Extension", "2018-05-18T04:00:00Z", 2018, 5, "2018-05-18T04:00:00Z", null, "2018-05-18T11:47:45Z", null, 0, 0, "0900006483279624"], ["FDA-2017-N-6189-0470", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Commonwealth of Virginia Department of Agriculture and Consumer Services", "Other", "Request for Extension", "2018-05-15T04:00:00Z", 2018, 5, "2018-05-15T04:00:00Z", null, "2018-05-15T12:10:46Z", null, 0, 0, "090000648325d390"], ["FDA-2017-N-6189-0459", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from ITG Brands", "Other", "Request for Extension", "2018-05-11T04:00:00Z", 2018, 5, "2018-05-11T04:00:00Z", null, "2018-05-11T17:37:30Z", null, 0, 0, "090000648325ad95"], ["FDA-2017-N-6189-0458", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from North Carolina Department of Agriculture and Consumer Services  Agricultural Services", "Other", "Request for Extension", "2018-05-11T04:00:00Z", 2018, 5, "2018-05-11T04:00:00Z", null, "2018-05-11T17:37:57Z", null, 0, 0, "09000064832591e3"], ["FDA-2017-N-6189-0455", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from R Street Institute", "Other", "Request for Extension", "2018-05-11T04:00:00Z", 2018, 5, "2018-05-11T04:00:00Z", null, "2018-05-11T17:18:47Z", null, 0, 0, "090000648325586e"], ["FDA-2017-N-6189-0430", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Universal Corporation", "Other", "Electronic Regulation from Form", "2018-05-08T04:00:00Z", 2018, 5, "2018-05-08T04:00:00Z", null, "2018-05-08T12:16:33Z", null, 0, 0, "09000064832234ff"], ["FDA-2017-N-6189-0429", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Altria Client Services LLC", "Other", "Electronic Regulation from Form", "2018-05-08T04:00:00Z", 2018, 5, "2018-05-08T04:00:00Z", null, "2018-05-08T12:16:26Z", null, 0, 0, "09000064832236b9"], ["FDA-2017-N-6189-0433", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Virginia Farm Bureau Federation", "Other", "Electronic Regulation from Form", "2018-05-08T04:00:00Z", 2018, 5, "2018-05-08T04:00:00Z", null, "2018-05-08T12:17:06Z", null, 0, 0, "09000064832282bb"], ["FDA-2017-N-6189-0403", "FDA", "FDA-2017-N-6189", "Nicotine Level ANPRM as Submitted to OMB Tab A of Direction to add documents to the docket in accordance with EO 12866", "Other", "Draft", "2018-04-27T04:00:00Z", 2018, 4, "2018-04-27T04:00:00Z", null, "2018-04-27T12:01:25Z", null, 0, 0, "09000064831e9654"], ["FDA-2017-N-6189-0405", "FDA", "FDA-2017-N-6189", "Nicotine Level ANPRM as Cleared by OMB Tab C of Direction to add documents to the docket in accordance with EO 12866", "Other", "Draft", "2018-04-27T04:00:00Z", 2018, 4, "2018-04-27T04:00:00Z", null, "2018-04-27T12:01:41Z", null, 0, 0, "09000064831e9656"], ["FDA-2017-N-6189-0404", "FDA", "FDA-2017-N-6189", "Nicotine Level ANPRM Track Changes Tab B of Direction to add documents to the docket in accordance with EO 12866", "Other", "Draft", "2018-04-27T04:00:00Z", 2018, 4, "2018-04-27T04:00:00Z", null, "2018-04-27T12:01:32Z", null, 0, 0, "09000064831e9655"], ["FDA-2017-N-6189-0402", "FDA", "FDA-2017-N-6189", "Memorandum to FDA DMS on Nicotine Level ANPRM", "Other", "Action Memo or Letter", "2018-04-27T04:00:00Z", 2018, 4, "2018-04-27T04:00:00Z", null, "2018-04-27T12:01:20Z", null, 0, 0, "09000064831e9653"], ["FDA-2017-N-6189-0407", "FDA", "FDA-2017-N-6189", "Extension of Comment Period from North Carolina Farm Bureau Federation, Inc.", "Other", "Electronic Regulation from Form", "2018-04-27T04:00:00Z", 2018, 4, "2018-04-27T04:00:00Z", null, "2018-04-27T15:41:36Z", null, 0, 0, "09000064831ecc6f"], ["FDA-2017-N-6189-0389", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from The Council for Burley Tobacco", "Other", "Request for Extension", "2018-04-26T04:00:00Z", 2018, 4, "2018-04-26T04:00:00Z", null, "2018-04-26T14:28:46Z", null, 0, 0, "09000064831c5edb"], ["FDA-2017-N-6189-0208", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from National Association of Tobacco Outlets, Inc.", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T02:01:31Z", null, 0, 0, "0900006483145105"], ["FDA-2017-N-6189-0210", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Convenience Distribution Association", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T02:27:16Z", null, 0, 0, "0900006483173fda"], ["FDA-2017-N-6189-0205", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from", "Other", "Electronic Regulation from Form", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T00:56:59Z", null, 0, 0, "090000648305ba71"], ["FDA-2017-N-6189-0204", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Altria Client Services", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-18T23:28:32Z", null, 0, 0, "090000648303edba"], ["FDA-2017-N-6189-0209", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from The Heartland Institute", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T02:20:12Z", null, 0, 0, "090000648314fa61"], ["FDA-2017-N-6189-0207", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from RAI Services Company", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T01:56:22Z", null, 0, 0, "090000648304ef16"], ["FDA-2017-N-6189-0206", "FDA", "FDA-2017-N-6189", "Request for Extension of Comment Period from Altria Client Services", "Other", "Request for Extension", "2018-04-18T04:00:00Z", 2018, 4, "2018-04-18T04:00:00Z", null, "2018-04-19T01:26:04Z", null, 0, 0, "09000064830854b5"], ["FDA-2017-N-6189-0079", "FDA", "FDA-2017-N-6189", "Reference 111_Lindson_2010_Reduction Versus Abrupt Cessation in Smokers Who Want to Quit", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:21Z", null, 0, 0, "0900006483017c78"], ["FDA-2017-N-6189-0164", "FDA", "FDA-2017-N-6189", "Reference 116_CRM_2005_Determination of Nicotine in Tobacco and Tobacco Products by Gas Chromatographic Analysis", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:08Z", null, 0, 0, "0900006483017c7d"], ["FDA-2017-N-6189-0102", "FDA", "FDA-2017-N-6189", "Reference 123_NRP_1989_Nicotine Reduction Program", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:36Z", null, 0, 0, "0900006483017c8a"], ["FDA-2017-N-6189-0100", "FDA", "FDA-2017-N-6189", "Reference 125_Ding_2017_Chemical Characterization of Mainstream Smoke from Spectrum Variable Nicotine Research Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:35Z", null, 0, 0, "0900006483017c8c"], ["FDA-2017-N-6189-0096", "FDA", "FDA-2017-N-6189", "Reference 129_Har_Monthly Project Development Report", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:32Z", null, 0, 0, "0900006483017c97"], ["FDA-2017-N-6189-0111", "FDA", "FDA-2017-N-6189", "Reference 151_Boswall_1971_Project T-6534  Tobacco for Reconstitution", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:44Z", null, 0, 0, "0900006483017cc0"], ["FDA-2017-N-6189-0172", "FDA", "FDA-2017-N-6189", "Reference 80_Counts l_2005_Smoke composition and predicting realtionships for international commercial cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:56:35Z", null, 0, 0, "0900006483017dc0"], ["FDA-2017-N-6189-0083", "FDA", "FDA-2017-N-6189", "Reference 107_Rose 06_Precessation Treatment with Nicotine Skin Patch Facilitates Smoking Cessation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:24Z", null, 0, 0, "0900006483017e38"], ["FDA-2017-N-6189-0138", "FDA", "FDA-2017-N-6189", "Reference 161_Hash_2014_Reducing Levels of Nicotinice Alkaloids in Plants", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:03Z", null, 0, 0, "0900006483017eb2"], ["FDA-2017-N-6189-0134", "FDA", "FDA-2017-N-6189", "Reference 165_Ridomil_800000 D.R.S. Ridomil Experiment", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:01Z", null, 0, 0, "0900006483017eca"], ["FDA-2017-N-6189-0016", "FDA", "FDA-2017-N-6189", "Reference 5_Ben 07_Nicotine and Carcinogen Exposure With Smoking of Progressively Reduced Nicotine Content Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:27Z", null, 0, 0, "0900006483017bc9"], ["FDA-2017-N-6189-0003", "FDA", "FDA-2017-N-6189", "Reference 18_Lenk_2014_Do Sources of Cigarettes Among Adolescents Vary by Age Over Time", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:19Z", null, 0, 0, "0900006483017bfc"], ["FDA-2017-N-6189-0031", "FDA", "FDA-2017-N-6189", "Reference 29_Fong_2004_The Near-Universal Experience of Regret Among Smokers in Four Countries Findings From the International Tobacco Control Policy", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:36Z", null, 0, 0, "0900006483017c23"], ["FDA-2017-N-6189-0028", "FDA", "FDA-2017-N-6189", "Reference 32_Christensen_2018_StudyAssociation of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:35Z", null, 0, 0, "0900006483017c2c"], ["FDA-2017-N-6189-0024", "FDA", "FDA-2017-N-6189", "Reference 36_94 SG_Youth & Tobacco Preventing Tobacco Use Among Young People", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:32Z", null, 0, 0, "0900006483017c33"], ["FDA-2017-N-6189-0165", "FDA", "FDA-2017-N-6189", "Reference 79_ART_Alkaloid Reduced Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:09Z", null, 0, 0, "0900006483017dbf"], ["FDA-2017-N-6189-0082", "FDA", "FDA-2017-N-6189", "Reference 108_Walker 12_The Combined Effect of Very Low Nicotine Content Cigarettes, Used as an Adjunct to Usual Quitline Care", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:23Z", null, 0, 0, "0900006483017e39"], ["FDA-2017-N-6189-0097", "FDA", "FDA-2017-N-6189", "Reference 128_Wayne_2012_Tobacco Industry Research on Modification of Nicotine Content in Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:33Z", null, 0, 0, "0900006483017c8f"], ["FDA-2017-N-6189-0123", "FDA", "FDA-2017-N-6189", "Reference 139_Crouse_1987_Communication with Michael Ogden RJR Bowman Gray Development Center", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:54Z", null, 0, 0, "0900006483017ca9"], ["FDA-2017-N-6189-0115", "FDA", "FDA-2017-N-6189", "Reference 147_Hempfling_1987_Philip Morris and the New Biotechnology", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:48Z", null, 0, 0, "0900006483017cbc"], ["FDA-2017-N-6189-0051", "FDA", "FDA-2017-N-6189", "Reference 47_CDC 5708_2008_Surveillance for cancers associated with tobacco use-United States_1999-2004", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:50Z", null, 0, 0, "0900006483017d4e"], ["FDA-2017-N-6189-0044", "FDA", "FDA-2017-N-6189", "Reference 54_Henn 98_Reducing the Addictiveness of Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:45Z", null, 0, 0, "0900006483017d7a"], ["FDA-2017-N-6189-0166", "FDA", "FDA-2017-N-6189", "Reference 78_NIH_Notice of Availability of Nicotine Research Cigarettes Through NIDA\u2019s Drug Supply Program", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:10Z", null, 0, 0, "0900006483017dbe"], ["FDA-2017-N-6189-0008", "FDA", "FDA-2017-N-6189", "Reference 13_IOM 07_2007_Ending the Tobacco Problem  A Blueprint for the Nation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:23Z", null, 0, 0, "09000064830178c1"], ["FDA-2017-N-6189-0130", "FDA", "FDA-2017-N-6189", "Reference 169_Geiss 75_Bw Process VI  Metabolism of Nicotine and Other Biochemistry of the Bw Process", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:59Z", null, 0, 0, "0900006483017ece"], ["FDA-2017-N-6189-0015", "FDA", "FDA-2017-N-6189", "Reference 6_NEJM_2015_Smoking and Mortality Beyond Established Causes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:26Z", null, 0, 0, "0900006483017bca"], ["FDA-2017-N-6189-0022", "FDA", "FDA-2017-N-6189", "Reference 38_Choi_1997_Which Adolescent Experimenters Progress to Established Smoking in the United States", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:31Z", null, 0, 0, "0900006483017c35"], ["FDA-2017-N-6189-0109", "FDA", "FDA-2017-N-6189", "Reference 152_Evans_1971_Low Nicotine Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:42Z", null, 0, 0, "0900006483017cc1"], ["FDA-2017-N-6189-0084", "FDA", "FDA-2017-N-6189", "Reference 106_Hats Kot 10_Reduced Nicotine Content Cigarettes Effects on Toxicant Exposure Dependence and Cessation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:25Z", null, 0, 0, "0900006483017e37"], ["FDA-2017-N-6189-0076", "FDA", "FDA-2017-N-6189", "Reference 114_TobLab_2014_Standard operating procedure for determination of nicotine in cigarette tobacco filler", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:20Z", null, 0, 0, "0900006483017c7b"], ["FDA-2017-N-6189-0161", "FDA", "FDA-2017-N-6189", "Reference 133_Dunsby_2004_A nicotine delivery device without the nicotine Tobacco industry development of low nicotine cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:06Z", null, 0, 0, "0900006483017c9c"], ["FDA-2017-N-6189-0160", "FDA", "FDA-2017-N-6189", "Reference 134_Tso 1972_The Potential for Producing Safer Cigarette Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:06Z", null, 0, 0, "0900006483017c9d"], ["FDA-2017-N-6189-0087", "FDA", "FDA-2017-N-6189", "Reference 103_Benowitz 2006_Nicotine Intake and Dose Response When Smoking Reduced-Nicotine Content Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:26Z", null, 0, 0, "0900006483017e34"], ["FDA-2017-N-6189-0019", "FDA", "FDA-2017-N-6189", "Reference 2_Ben 13_Reducing the nicotine content to make cigarettes less addictive", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:29Z", null, 0, 0, "0900006483017bc6"], ["FDA-2017-N-6189-0004", "FDA", "FDA-2017-N-6189", "Reference 17_10 SG_How Tobacco Smoke Causes Disease The Biology and Behavioral Basis for Smoking-Attributable Disease", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:20Z", null, 0, 0, "0900006483017bfa"], ["FDA-2017-N-6189-0027", "FDA", "FDA-2017-N-6189", "Reference 33_Rodriguez_2010_The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:34Z", null, 0, 0, "0900006483017c2f"], ["FDA-2017-N-6189-0070", "FDA", "FDA-2017-N-6189", "Reference 63_Fiore 15_Reduced-nicotine cigarettes_A promising regulatory pathway", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:02Z", null, 0, 0, "0900006483017c56"], ["FDA-2017-N-6189-0062", "FDA", "FDA-2017-N-6189", "Reference 71_Jacob_1999_Minor tobacco alkaloids as biomarkers for tobacco use", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:57Z", null, 0, 0, "0900006483017c5e"], ["FDA-2017-N-6189-0074", "FDA", "FDA-2017-N-6189", "Reference 59_06 SG_The health consequences of involuntary exposure to tobacco smoke", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:04Z", null, 0, 0, "0900006483017d7f"], ["FDA-2017-N-6189-0145", "FDA", "FDA-2017-N-6189", "Reference 154_BAT_1973_Research and Development Department  Progress in 1972 \u2013 Plans for 1973", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:06Z", null, 0, 0, "0900006483017eaa"], ["FDA-2017-N-6189-0017", "FDA", "FDA-2017-N-6189", "Reference 4_Hats 10_Reduced Nicotine Content Cigarettes Effects on Toxic Exposure, Dependence, and Cessation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:28Z", null, 0, 0, "0900006483017bc8"], ["FDA-2017-N-6189-0039", "FDA", "FDA-2017-N-6189", "Reference 21_CDC 6044_2011_Quitting Smoking Among Adults United States 2001- 2010", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:41Z", null, 0, 0, "0900006483017bff"], ["FDA-2017-N-6189-0025", "FDA", "FDA-2017-N-6189", "Reference 35_Weglicki_2008_Tobacco Use Assessment What Exactly Is Your Patient Using and Why Is It Important to Know", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:33Z", null, 0, 0, "0900006483017c31"], ["FDA-2017-N-6189-0068", "FDA", "FDA-2017-N-6189", "Reference 65_Scherer_1999_Smoking behaviour and compensation-a review of the literature", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:01Z", null, 0, 0, "0900006483017c58"], ["FDA-2017-N-6189-0067", "FDA", "FDA-2017-N-6189", "Reference 66_Grubbs_1991_Process for removal of basic materials", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:00Z", null, 0, 0, "0900006483017c59"], ["FDA-2017-N-6189-0148", "FDA", "FDA-2017-N-6189", "Reference 173_90 SG_1990_The Health Benefits of Smoking Cessation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:13Z", null, 0, 0, "0900006483017cdf"], ["FDA-2017-N-6189-0153", "FDA", "FDA-2017-N-6189", "Reference 178_Taylor_2002_Benefits of Smoking Cessation for Longevity_AJPH", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:16Z", null, 0, 0, "0900006483017ce5"], ["FDA-2017-N-6189-0060", "FDA", "FDA-2017-N-6189", "Reference 73_Djordjevic_1990_CORESTA Symposium, Kallithea Greece", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:56Z", null, 0, 0, "0900006483017db8"], ["FDA-2017-N-6189-0171", "FDA", "FDA-2017-N-6189", "Reference 77_Patent_Reducing Levels of Nicotinic Alkaloids in Plants", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:56:27Z", null, 0, 0, "0900006483017dbd"], ["FDA-2017-N-6189-0129", "FDA", "FDA-2017-N-6189", "Reference 170_Gravely_1973_Bw Process  IV Evaluation of Low Nicotine Cigarettes Use for Consumer Product Testing", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:58Z", null, 0, 0, "0900006483017ecf"], ["FDA-2017-N-6189-0158", "FDA", "FDA-2017-N-6189", "Reference 93_Perkins_2008_Mood Influences on Acute Smoking Responses Are Independent of Nicotine Intake and Dose Expectancy", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:55:03Z", null, 0, 0, "0900006483017c68"], ["FDA-2017-N-6189-0184", "FDA", "FDA-2017-N-6189", "Reference 94_Gross_1997_Nicotine Containing Versus De Nicotinized Cigarettes Effects on Craving and Withdrawal", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T16:03:58Z", null, 0, 0, "0900006483017c69"], ["FDA-2017-N-6189-0091", "FDA", "FDA-2017-N-6189", "Reference 99_Wu_2002_Determination of Nicotine and Other Minor Alkaloids in International Cigarettes by Solid Phase Microextraction and Gas Chromatography Mass", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:29Z", null, 0, 0, "0900006483017c6f"], ["FDA-2017-N-6189-0108", "FDA", "FDA-2017-N-6189", "Reference 117_Wu 98_Analytical Determination of Nicotine in Tobacco by Supercritical Fluid Chromatography\u2212Ion Mobility Detection", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:41Z", null, 0, 0, "0900006483017c7e"], ["FDA-2017-N-6189-0099", "FDA", "FDA-2017-N-6189", "Reference 126_Mon.7_The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:34Z", null, 0, 0, "0900006483017c8d"], ["FDA-2017-N-6189-0095", "FDA", "FDA-2017-N-6189", "Reference 130_unnamed_2016_Unnamed Report", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:31Z", null, 0, 0, "0900006483017c98"], ["FDA-2017-N-6189-0126", "FDA", "FDA-2017-N-6189", "Reference 136_Borriston_1984_.  Final Report 14-Day Single Dose Subacute Toxicity Study in the Rat With A-7 Borriston Project", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:57Z", null, 0, 0, "0900006483017c9f"], ["FDA-2017-N-6189-0120", "FDA", "FDA-2017-N-6189", "Reference 142_Roselius_1879_Process for the Extraction of Nicotine From Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:52Z", null, 0, 0, "0900006483017caf"], ["FDA-2017-N-6189-0113", "FDA", "FDA-2017-N-6189", "Reference 149_Sensa_1992_Sensa Business Plan Executive Summary", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:46Z", null, 0, 0, "0900006483017cbe"], ["FDA-2017-N-6189-0047", "FDA", "FDA-2017-N-6189", "Reference 51_Kenford_1994_Predicting Smoking Cessation Who Will Quit With and Without the Nicotine Patch", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:47Z", null, 0, 0, "0900006483017d52"], ["FDA-2017-N-6189-0176", "FDA", "FDA-2017-N-6189", "Reference 84_Sof rev_2012_The reinforcement threshold for nicotine as a target for tobacco control", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:58:32Z", null, 0, 0, "0900006483017df4"], ["FDA-2017-N-6189-0182", "FDA", "FDA-2017-N-6189", "Reference 90_Eid_2005_Placebo cigarettes in a spaced smoking paradigm", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T16:02:48Z", null, 0, 0, "0900006483017dfa"], ["FDA-2017-N-6189-0131", "FDA", "FDA-2017-N-6189", "Reference 168_Geiss_1972_Bw Process I  Reductions of Tobacco Nicotine Using Selected Bacteria", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:59Z", null, 0, 0, "0900006483017ecd"], ["FDA-2017-N-6189-0009", "FDA", "FDA-2017-N-6189", "Reference 12_Johnston 2005_Monitoring the Future national survey results on drug use 1975-2004", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:23Z", null, 0, 0, "09000064830178c0"], ["FDA-2017-N-6189-0021", "FDA", "FDA-2017-N-6189", "Reference List_Tobacco Product Standard for Nicotine Level of Combusted Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:30Z", null, 0, 0, "0900006483017bc4"], ["FDA-2017-N-6189-0018", "FDA", "FDA-2017-N-6189", "Reference 3_Hats Heis 13_Dose Response Effects of Spectrum Research Cigarettes", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:28Z", null, 0, 0, "0900006483017bc7"], ["FDA-2017-N-6189-0040", "FDA", "FDA-2017-N-6189", "Reference 20_Grucza_2013_Long-Term Effects of Laws Governing Youth Access to Tobacco", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:42Z", null, 0, 0, "0900006483017bfe"], ["FDA-2017-N-6189-0173", "FDA", "FDA-2017-N-6189", "Reference 81_B&H 94_Establishing a nicotine threshold for addiction - the implications for tobacco regulation", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:56:40Z", null, 0, 0, "0900006483017df1"], ["FDA-2017-N-6189-0139", "FDA", "FDA-2017-N-6189", "Ref. 160_Cohen_1971_Minutes of Meeting on May 6, 1971", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:53:03Z", null, 0, 0, "0900006483017eb0"], ["FDA-2017-N-6189-0098", "FDA", "FDA-2017-N-6189", "Reference 127_Farone_U.S. District Court for the District of Columbia United States of America, Plaintiff, versus Philip Morris, USA, et al., defendants", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:34Z", null, 0, 0, "0900006483017c8e"], ["FDA-2017-N-6189-0124", "FDA", "FDA-2017-N-6189", "Reference 138_PM_Untitled Chart", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:55Z", null, 0, 0, "0900006483017ca8"], ["FDA-2017-N-6189-0122", "FDA", "FDA-2017-N-6189", "Reference 140_Ruiz_2008_Supercritical Fluid Extraction of Tobacco Leaves A Preliminary Study on the Extraction of Solanesol", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:53Z", null, 0, 0, "0900006483017caa"], ["FDA-2017-N-6189-0118", "FDA", "FDA-2017-N-6189", "Reference 144_Crouse 76_Nicotine Extraction Preliminary Study of Methods for High Nicotine Leaf Extraction June 20 1976", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:52:51Z", null, 0, 0, "0900006483017cb1"], ["FDA-2017-N-6189-0053", "FDA", "FDA-2017-N-6189", "Reference 45_Chaiton_2016_Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers", "Supporting & Related Material", "Background Material", "2018-03-16T04:00:00Z", 2018, 3, null, null, "2018-03-16T15:51:51Z", null, 0, 0, "0900006483017d4c"]], "truncated": false, "filtered_table_rows_count": 210, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2017-N-6189"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2017-N-6189", "results": [{"value": "FDA", "label": "FDA", "count": 210, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2017-N-6189", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 184, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 24, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2017-N-6189", "results": [{"value": 2018, "label": 2018, "count": 210, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&posted_year=2018", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet=comment_start_date"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_facet_date=last_modified"}], "next": "2018-03-16T04~3A00~3A00Z,FDA-2017-N-6189-0053", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2017-N-6189&_next=2018-03-16T04~3A00~3A00Z%2CFDA-2017-N-6189-0053&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 941.7430390021764, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}